Presentations, Publications and Prospectuses
- Capital Marked Update (14.04.2026)
- Prospectus: Listing of shares - incl. appendices (15.01.26)
- Article in Immunotherapy Advances: Preclinical assessment of MAGE-A4-specific TCR-NK cells against solid tumors (16.12.2025)
- Prospectus: Business Combination Zelluna and Ultimovacs - incl. appendices (28.02.25)
- Presentation og the Business combination of Zelluna and Ultimovacs (18.12.2024)
Zelluna in the media
- DNB Asset Management podcast: "Hvor går helse- og bioteksektoren?" (24.02.2026)
- Radium podcast: Episode 344 - Zelluna with Anders Tuv, Chair of the Board in the Company and Managing Director in Radforsk Invest (13.01.2026)
- Radium podcast: Episode 330 - Zelluna with CEO Namir Hassan (20.05.2025)
- Beyond BiotechWebcast: TCR-NK: A novel cell therapy transforming cancer treatment (02.05.2025)
- DNB Webcast: Zelluna with CEO Namir Hassan (23.04.2025)